(VIANEWS) – FREY (FREY.PA), DOCK.PETR.AMBES AM (DPAM.PA), YARA INTERNATIONAL (YAR.OL) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. FREY (FREY.PA)
216.87% Payout Ratio
Frey SA engages in developing, owning, and managing commercial real estate assets primarily located in France. The company primarily operates environmental retail parks. As of December 31, 2010, its assets included 62,000 square meters. The company was formerly known as Immobiliere Frey SA and changed its name to Frey SA in June 2009. Frey SA was founded in 1983 and is based in Reims, France.
Earnings Per Share
As for profitability, FREY has a trailing twelve months EPS of €0.6.
PE Ratio
FREY has a trailing twelve months price to earnings ratio of 46. Meaning, the purchaser of the share is investing €46 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.93%.
More news about FREY.
2. DOCK.PETR.AMBES AM (DPAM.PA)
86.49% Payout Ratio
Les Docks des Pétroles d'Ambès -SA engages in the storage and shipping of petroleum products in France. It stores and distributes species, diesel, and combustibles, as well as bio, jet, technical, and marine fuel products. The company was founded in 1930 and is based in Carbon-Blanc, France.
Earnings Per Share
As for profitability, DOCK.PETR.AMBES AM has a trailing twelve months EPS of €49.45.
PE Ratio
DOCK.PETR.AMBES AM has a trailing twelve months price to earnings ratio of 10.31. Meaning, the purchaser of the share is investing €10.31 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.45%.
Moving Average
DOCK.PETR.AMBES AM’s value is under its 50-day moving average of €514.12 and above its 200-day moving average of €507.51.
Volume
Today’s last reported volume for DOCK.PETR.AMBES AM is 1 which is 88.88% below its average volume of 9.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.1%, now sitting on 19.11M for the twelve trailing months.
Yearly Top and Bottom Value
DOCK.PETR.AMBES AM’s stock is valued at €510.00 at 17:10 EST, under its 52-week high of €555.00 and way higher than its 52-week low of €450.00.
More news about DOCK.PETR.AMBES AM.
3. YARA INTERNATIONAL (YAR.OL)
45.52% Payout Ratio
Yara International ASA provides crop nutrition and industrial solutions in Norway, European Union, Europe, Africa, Asia, North and Latin America, Australia, and New Zealand. The company offers ammonium- and urea-based fertilizers; compound fertilizers that contain nutrients, such as nitrogen, phosphorus, and potassium; coatings; biostimulants; organic-based fertilizers; green fertilizers are nitrate-based mineral fertilizers, as well as foliar and fertigation solutions; and nitrate, calcium nitrate, micronutrient, and fertigation and urea fertilizers. It also offers digital solutions, such as variable rate application solutions; N-Sensor, a tractor-mounted hardware; N-Tester, a handheld nitrogen measurement tool; YaraFX Insight, an agricultural API; and Atfarm, a digital toolbox for farmer. The company sells its products under YaraBela, YaraMila, YaraLiva, YaraVita, YaraRega, YaraTera, YaraSuna, and YaraVera and brands. Yara International ASA was founded in 1905 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, YARA INTERNATIONAL has a trailing twelve months EPS of kr11.07.
PE Ratio
YARA INTERNATIONAL has a trailing twelve months price to earnings ratio of 26.63. Meaning, the purchaser of the share is investing kr26.63 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.69%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 29, 2024, the estimated forward annual dividend rate is 5 and the estimated forward annual dividend yield is 1.58%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 137.3% and a drop 2.1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 11%, now sitting on 14.15B for the twelve trailing months.
Yearly Top and Bottom Value
YARA INTERNATIONAL’s stock is valued at kr294.80 at 17:10 EST, way under its 52-week high of kr419.00 and above its 52-week low of kr286.60.
More news about YARA INTERNATIONAL.
4. SARTORIUS STED BIO (DIM.PA)
38.55% Payout Ratio
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.31%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 2.75B for the twelve trailing months.
Sales Growth
SARTORIUS STED BIO’s sales growth is 7.9% for the ongoing quarter and 6.5% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 2, 2024, the estimated forward annual dividend rate is 0.69 and the estimated forward annual dividend yield is 0.39%.
Volume
Today’s last reported volume for SARTORIUS STED BIO is 48852 which is 29.49% below its average volume of 69287.
More news about SARTORIUS STED BIO.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).
More news about 1.
